Choledochal Cyst: Review of the Literature on Etiology and a Representative Case Study by Taylor, Mark A.
Warning Concerning Copyright Restrictions 
 
The Copyright Law of the United States (Title 17, United States Code) governs the 
making of photocopies or other reproductions of copyrighted materials. 
 
Under certain conditions specified in the law, libraries and archives are authorized 
to furnish a photocopy or other reproduction. One of these specified conditions is 
that the photocopy or reproduction is not to be used for any purpose other than 
private study, scholarship, or research. If electronic transmission of reserve 
material is used for purposes in excess of what constitutes "fair use," that user may 






















A thesis submitted in partial fulfillment  
of the requirements for the degree of 
 










Mark A. Taylor II 
 



















We recommend that the thesis 


















be accepted in partial fulfillment of the 
requirements for the degree of 
 



















Choledochal cysts are fluid-filled dilations of the common bile duct or hepatic 
duct, which currently have an unknown etiology (Singham, Yoshida and Scudamore, 
2009).  The current ideas of the etiology signify that choledochal cysts are caused by a 
reflux of pancreatic juices into the common bile duct, which causes increased expression 
of matrix metalloproteinase-1 and -2 and the formation of protein plugs (Babbitt, 
Starshak and Clemett, 1973; Mao, Tang and Ruan, 2008; Kaneko et al., 2007).  The 
combination of these events causes increased intraluminal pressure and, consequently, 
cyst formation (Babbitt, Starshak and Clemett, 1973; Mao, Tang and Ruan, 2008; Kaneko 
et al., 2007). 
A case study of a 5 day old patient diagnosed with a choledochal cyst is discussed 











Table of Contents 
Abstract ................................................................................................................................ i 
Table of Contents ................................................................................................................ ii 
List of Tables ..................................................................................................................... iv 









Historical Background .........................................................................................................9 
Evolution of the Classification.................................................................................9 
Evolution of the Treatment ....................................................................................10 
Literature Review...............................................................................................................12 
Babbitt’s Hypothesis ..............................................................................................12 
Incorporation of New Ideas into Babbitt’s Hypothesis..........................................13 
Case Study .........................................................................................................................17 
Chief Complaint .....................................................................................................17 
History of Present Illness .......................................................................................17 
Social and Family History .....................................................................................18 
iii 
 
Physical Exam ........................................................................................................18 
Laboratory and Imaging Findings ..........................................................................20 
Diagnosis and Treatment .......................................................................................23 
Follow-up ...............................................................................................................24 
Case Study Description ......................................................................................................25 
Presentation ............................................................................................................25 
Differential Diagnosis ............................................................................................26 
History of Present Illness .......................................................................................29 
Family History .......................................................................................................30 
Physical Examination.............................................................................................30 
Laboratory Work-up ..............................................................................................30 
Imaging Studies .....................................................................................................34 
Treatment ...............................................................................................................35 
Discussion ..........................................................................................................................37 











List of Tables 
























List of Figures 
Figure 1. A comparison of a typically developed pancreaticobiliary junction and a 
pancreaticobiliary duct maljunction that occurs with a choledochal cyst................2 
Figure 2. Todani’s classification of choledochal cysts. .......................................................4 
Figure 3. Representation of a Roux-en-Y hepaticojejunostomy. .........................................6 
Figure 4. Hypothesized mechanism of protein plug formation in choledochal cysts. .......15 
Figure 5. Ultrasound of neonate with a choledochal cyst. .................................................34 







Choledochal cysts are fluid-filled dilations of the common bile duct or hepatic 
duct (see figure 1) (Singham, Yoshida and Scudamore, 2009).  Approximately 90% of 
choledochal cysts occur with an anomalous pancreaticobiliary duct maljunction 
(Singham, Yoshida and Scudamore, 2009). Anomalous pancreaticobiliary duct 
maljunction occurs when the pancreatic duct joins with the common bile duct 1cm or 
more before the duodenum (Miyano and Yamataka, 1997).  This maljunction of the 
common bile duct and pancreatic duct allows for the regurgitation of pancreatic juices 
into the common bile duct, which is believed to play a role in the pathogenesis of 
choledochal cysts (Babbitt, Starshak and Clemett, 1973).  However, this theory does not 
take into account those cases of choledochal cysts that occur in the absence of an 
anomalous pancreaticobiliary duct maljunction, which is why the etiology of choledochal 




Figure 1. A comparison of a typically developed pancreaticobiliary 
junction and a pancreaticobiliary duct maljunction that occurs with a 
choledochal cyst. Note the junction of the common duct and the chief 
pancreatic duct is more distal to the duodenum in a patient with a 
choledochal cyst than it is in a patient that has a typically developed 
pancreaticobiliary junction.  Also note the presence of a cystic dilation of 
the common bile duct in the figure representing a choledochal cyst. Image 
from Donald Babbitt et al., "Choledochal Cyst: A Concept of Etiology" 
(American Journal of Roentgenology, Radium Therapy, and Nuclear 
Medicine 119.1, 1973) 57-62. Print. 
There are two common theories about the etiology of choledochal cysts.  
Babbitt’s theory states that cysts are caused by the reflux of pancreatic juices into the 
common bile duct due to the presence of an abnormal pancreaticobiliary duct maljunction 
(Babbitt, Starshak and Clemett, 1973).  This theory, however, does not take into account 
those cases of choledochal cysts that occur without the presence of anomalous 
pancreaticobiliary duct maljunction.  Davenport and Basu (2005) suggest that 
choledochal cysts are caused by an over-proliferation of epithelial cells during the 
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embryogenesis of the common bile duct.  No theory has been proposed that fully explains 
the pathogenesis of choledochal cysts. 
Classification 
Choledochal cysts are classified as follows: type I is a dilation of either a portion 
of or the entire common bile duct; type II is a diverticulum projecting from the common 
bile duct; type III is a dilation of the junction of the common bile duct and the duodenum 
or of the common bile duct and the pancreatic duct; type IVa consists of multiple cysts of 
the intra- and extrahepatic ducts; type IVb consists of multiple cysts of only the 
extrahepatic ducts; type V is a dilation of the intrahepatic ducts (see figure 2) (Todani et 
al., 1977). Lilly, Stellin, and Karrer (1985) have described patients with choledochal cyst-
like symptoms, such as obstructive jaundice and abdominal pain, but without the actual 
cyst present. These patients exhibited the same histology of the common bile duct as 
patients with actual cystic dilations, and, because of the similarities of the symptoms and 
histology of these patients to that of patients with actual cystic dilations of the common 





Figure 2. Todani’s classification of choledochal cysts.  The shaded portion 
of each image represents the choledochal cyst. Image from Takuji Todani 
et al., "Congenital Bile Duct Cysts: Classification, Operative Procedures, 
and Review of Thirty-Seven Cases Including Cancer Arising from 
Choledochal Cyst." (The American Journal of Surgery. Vol. 134. United 
States, 1977) 263-9. Print. 
Presentation 
The presentation of choledochal cysts varies widely based on age, but most cases 
of choledochal cysts present with one or more symptoms from the classic triad: pain in 
the upper right quadrant, jaundice, and a mass in the upper right quadrant (Singham, 
Yoshida and Scudamore, 2009).  Patients under the age of one typically present with 
jaundice and acholic stools (Vijayaraghavan et al., 2006).  Patients between one and 
twelve years of age typically present with pain and jaundice (Vijayaraghavan et al., 
2006).  In adults with choledochal cysts, upper right quadrant pain, nausea, and vomiting 
are the most common findings (Wiseman et al., 2005). 
Epidemiology 
The epidemiology of choledochal cysts is peculiar. The prevalence of choledochal 
cysts in the western countries is very low; between 1 in 100,000 and 1 in 150,000 
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individuals develop choledochal cysts (Lipsett and Pitt, 2003).  However, in Asia, the 
prevalence is much higher; approximately 1 in 1000 individuals develop choledochal 
cysts in Asia (Lipsett and Pitt, 2003). Choledochal cysts also occur in women around 
75% to 80% more often than they do in men (Lipsett and Pitt, 2003). Choledochal cysts 
can present from the prenatal stage to adulthood, but two-thirds of choledochal cysts 
present before the age of ten (Singham, Yoshida and Scudamore, 2009).  The 
epidemiology of choledochal cysts could offer a great amount of insight into the etiology 
of the disease.  By isolating the differences between the populations that have a higher 
risk of becoming diagnosed with choledochal cysts and those that do not, the cause of the 
disease might be elucidated. 
Treatment 
The treatment of choledochal cysts has evolved since their discovery, but the most 
widely accepted treatment today is the excision of the cyst with a Roux-en-Y 
hepaticojujenostomy (see figure 3) (Shimotakahara et al., 2005).  This procedure involves 
a complete removal of the cyst followed by connecting the jejunum portion of the small 
intestine to the common hepatic duct and connecting the duodenum portion of the small 
intestine to the jejunum (Shimotakahara et al., 2005).  This method is particularly 
successful because it prevents post-operative complications, such as gastric bile reflux, 
which can lead to cholangiocarcinoma (Shimotakahara et al., 2005).  This method is also 
more commonly performed in a minimally invasive laparoscopic, or “keyhole,” fashion 
in Asia, which aims to decrease patient post-operative pain, risk of infection, cosmetic 
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consequences, and recovery time when compared to open abdomen surgery (Gupta et al., 
2009). 
 
Figure 3. Representation of a Roux-en-Y hepaticojejunostomy. Image 
from CPMC Sutter Health; Management of Bile Duct Problems Procedure 
Profile; CPMC, 2011; Web; 04 Feb. 2011. 
Malignance 
Kasai, Asakura, and Taira (1970) were the first to report that choledochal 
cysts lead to an increased incidence of malignance compared to the incidence in 
patients without choledochal cysts. Malignant change in patients with choledochal 
cysts is thought to occur due to inflammation of the biliary tract caused by the 
cholangitis that is associated with choledochal cysts, the mixing of pancreatic 
juices and bile, or cholestasis (Bismuth and Krissat, 1999; Holzinger, Z'Graggen 
and Buchler, 1999; Singham, Yoshida and Scudamore, 2009).  This chronic 
inflammation leads to dysplasia of the common bile duct and destruction of the 
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mucin-secreting cells of the common bile duct (Bismuth and Krissat, 1999; 
Singham, Yoshida and Scudamore, 2009).  Inflammation of the common bile duct 
causes immune cells to secrete carcinogenic compounds into the inflamed cells, 
which, under normal conditions, are discarded by the cell (Holzinger, Z'Graggen 
and Buchler, 1999). However, in cholangiocarcinoma, the mechanisms for 
disposing of these carcinogens are defective (Holzinger, Z'Graggen and Buchler, 
1999). The reflux of pancreatic juices into the common bile duct is also thought to 
cause K-ras mutations and overexpression of p53 (Holzinger, Z'Graggen and 
Buchler, 1999; Singham, Yoshida and Scudamore, 2009).  Both K-ras mutations 
and overexpression of p53 in the common bile duct can lead to a cancerous state 
in the common bile duct (Holzinger, Z'Graggen and Buchler, 1999; Singham, 
Yoshida and Scudamore, 2009). 
The malignant cells of the common bile duct that originate at the 
choledochal cyst can spread in the common bile duct past the noticeable borders 
of the choledochal cyst (Holzinger, Z'Graggen and Buchler, 1999).  For this 
reason, complete excision of the choledochal cyst does not eliminate the chance 
of cancer of the common bile duct (Holzinger, Z'Graggen and Buchler, 1999). 
Consequently, life-long observation of a patient after excision of a choledochal 
cyst is recommended (Holzinger, Z'Graggen and Buchler, 1999). 
Purpose 
This study into choledochal cysts may help to eliminate some unknowns 
in the etiology of choledochal cysts by amalgamating the current ideas about the 
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etiology and providing a unifying theory. This study also aims to increase the 
awareness of choledochal cysts as a possible cause of jaundice in infants, even 


















Evolution of the Classification 
Vater and Ezler were the first people to publish a description of the anatomical 
structure of a choledochal cyst in 1723 (Lipsett et al., 1994). In 1852, Douglas (1852) 
published the first well-documented report of a choledochal cyst in one of his patients, 
who presented with the classical triad of symptoms.  After Douglas’s report, multiple 
types of choledochal cysts were discovered, and, in 1959, Alonso-Lej, Rever Jr., and 
Pessagno  (1959) devised a three class system for classifying the biliary abnormalities by 
classifying choledochal cysts as type I, which is a dilation of part of or the entire common 
bile duct, type II, which is a diverticulum off of the common bile duct, and type III, 
which is a dilation of the junction of the common bile duct and the duodenum or of the 
common bile duct and the pancreatic duct and is termed a choledochocele.  In 1958, 
Caroli et al. (1958) described a fourth type of choledochal cyst, which consisted of 
dilations of the intrahepatic ducts, and, in 1977, Todani et al. (1977) developed the 
current five class classification system of choledochal cysts by adding two classes of 
choledochal cysts to the system devised by Alonso-Lej et al. (1959).  The classes added 
to the Alonso-Lej system were type IVa and IVb, which consist of multiple cysts of the 
intra- and extrahepatic ducts and multiple cysts of only the extrahepatic ducts, 
respectively, and type V, which is the choledochal cyst discovered by Caroli et al. (1958) 
(Todani et al., 1977). In 2004, Visser et al. (2004) proposed the rejection of the Todani 
classification system because Visser et al. hypothesized that the different types of 
choledochal cysts are distinct diseases with different pathogeneses.  Visser et al. (2004) 
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suggested that choledochal cysts should be classified using a system that refers to each 
type of choledochal cyst using descriptive terms.  Visser et al. (2004) also suggested that 
type I and IV cysts are actually the same disease because Visser et al. asserted that 
dilation of the intrahepatic ducts is always present with type I choledochal cysts, but to a 
varying degree.  Visser et al. (2004) proposed replacing the Todani classification system 
with the following four class system: Type I and IV would be encompassed in a type 
called choledochal cyst, type II would be renamed choledochal diverticulum, type III 
would be termed choledochocele, and type V would be named Caroli Disease. However, 
this classification system has yet to be widely accepted. 
Evolution of the Treatment 
Douglas (1852), who published the first documented case of a choledochal cyst, 
treated his patient by draining the cyst with a trocar, treating the area with hot 
compresses, and prescribing the patient laxatives.  However, Douglas’s patient died six 
months after entering into his care (Douglas, 1852). The first accepted treatment of 
choledochal cysts was marsupialization, which involved creating a slit into the cyst and 
suturing the cyst in a way that allowed the cyst to drain freely into the abdominal cavity 
(Kasai, Asakura and Taira, 1970). Marsupialization was quickly abandoned due to the 
high mortality rate associated with this procedure (Kasai, Asakura and Taira, 1970). In 
1953, Gross (1953) outlined a treatment that involved internal drainage of the cyst along 
with a Roux-en-Y cystoduodenostomy or cystojejunostomy procedure. However, the 
procedure devised by Gross (1953) only temporarily relieved the symptoms; the patients 
later returned with the same symptoms because the cyst continually refilled with fluid, 
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which left the patient vulnerable to cholangitis and cholangiocarcinoma (Kasai, Asakura 
and Taira, 1970).  Golder Lewis McWhorter (1924) performed the first surgical removal 
of a choledochal cyst in 1924 by excising the cyst and creating an anastomosis between 
the common hepatic duct and the duodenum. McWhorter (1924) argued that the excision 
of the choledochal cyst offered the best option for treatment because excision better 
prevented the recurrence of symptoms and offered the best prognosis for the patient.  
However, internal drainage of the cyst remained the favored method of treatment of 
choledochal cysts because surgical technique at the time caused high mortality rates in 
patients that had complete excision of the cyst (Kasai, Asakura and Taira, 1970). From 
1981 to 1983, after surgical technique improved, the excision of the choledochal cyst and 
the creation of an anastomosis between the common bile duct and the jejunum became 
the dominant form of treatment of choledochal cysts (Kasai, Asakura and Taira, 1970). 
This procedure was replaced as the favored method of treatment of choledochal cysts in 
1984 by the Roux-en-Y hepaticojejunostomy because the Roux-en-Y 
hepaticojejunostomy allows the bile to empty into the duodenum, which is the normal 
physiological site of entry (see figure 3) (Kasai, Asakura and Taira, 1970).  This 
procedure remains the favored treatment of choledochal cysts today (Shimotakahara et 








The most widely accepted theory about the etiology of choledochal cysts is 
Babbitt’s hypothesis (Babbitt, Starshak and Clemett, 1973).  Babbitt, Starshak, and 
Clemett (1973) note the preponderance of anomalous pancreaticobiliary duct maljunction 
in patients with choledochal cysts.  Babbitt et al. (1973) theorize that this maljunction 
allows for the regurgitation of pancreatic juices into the common bile duct.  The pressure 
within the pancreatic duct is 22.1mmHg to 36.8mmHg, and the pressure in the common 
bile duct is 18.4mmHg to 22.1mmHg (Babbitt, Starshak and Clemett, 1973). Because 
fluid flows from higher pressure to lower pressure, fluid leaving the pancreatic duct 
regurgitates into the common bile duct (Babbitt, Starshak and Clemett, 1973). During 
normal development of the pancreaticobiliary junction, a sphincter forms to prevent this 
regurgitation; however, in patients with choledochal cysts, no sphincter is present to 
prevent this regurgitation of pancreatic juices into the common bile duct (Babbitt, 
Starshak and Clemett, 1973). This hypothesis that regurgitation of pancreatic juices 
causes choledochal cysts is supported by the fact that the fluid found in choledochal cysts 
is high in amylase content, a component of pancreatic juices (Babbitt, Starshak and 
Clemett, 1973).  With Babbitt’s hypothesis in mind, Joseph, Fonkalsrud, and Longmire 
(1965) propose that this regurgitation of pancreatic juices causes thickening of the wall of 
the common bile duct due to repeated incidences of cholangitis caused by a bacterial 




The importance of the anomalous pancreaticobiliary duct maljunction in the 
etiology of choledochal cysts is also illustrated by an experiment in which Ohkawa et al. 
(1981) created a model of anomalous pancreaticobiliary duct maljunction in dogs.  The 
creation of this anomalous pancreaticobiliary duct maljunction is done by performing a 
pancreaticocholecystostomy or a pancreaticocholedochostomy (Ohkawa et al., 1981). 
Both procedures result in cystic dilation of the common bile duct that is analogous to 
choledochal cysts in humans (Ohkawa et al., 1981). The cystic dilation is associated with 
pancreatic reflux into the common bile duct in both procedures, which is evidenced by 
the presence of amylase in the bile (Ohkawa et al., 1981).  These findings offer further 
support of Babbitt’s hypothesis. 
Incorporation of New Ideas into Babbitt’s Hypothesis 
The presence of pancreatic juices in choledochal cysts has been looked at by 
many as the possible cause of choledochal cysts.  However, unlike Babbitt et al. (1973), 
Kato, Asakura, and Kasai (1974) believe that the pancreatic juices might not directly 
cause the pathology noted in choledochal cysts.  Kato et al. (1974) assert that both 
structural weakness of the common bile duct and intraluminal pressure are necessary to 
produce surgically induced cystic dilations of the common bile duct in dogs.   
Kaneko et al. (2007) report a hypothesis for the etiology of choledochal cysts that 
incorporates increased intraluminal pressure and reflux of pancreatic juices into the 
common bile duct. The pancreatic juice in choledochal cysts contains, among other 
things, activated trypsin and lithostathine (Kaneko et al., 2007).  Kaneko et al. (1974) 
theorize that protein plugs are present in as much as 40% of cases of choledochal cysts.  
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Protein plugs are solid masses of protein that obstruct the bile duct and pancreatic duct 
(Kaneko et al., 2007). This blockage of the ducts leads to an increase in intraductal 
pressure and the resulting symptoms of choledochal cysts (Kaneko et al., 2007).  These 
protein plugs are composed predominately of lithostathine (Kaneko et al., 2007).  
Lithostathine is secreted in a soluble form by the pancreas; however, the purpose of 
lithostathine secretion is currently unknown (Kaneko et al., 2007). Trypsinogen, also 
secreted by the pancreas, is cleaved to produce its active form, trypsin, in order to digest 
proteins in the small intestine (Kaneko et al., 2007).  However, trypsin also cleaves 
lithostathine into lithostathine S1 (Kaneko et al., 2007).  Lithostathine S1 is insoluble and 
is the primary component of protein plugs (Kaneko et al., 2007).  Because of these 
findings, Kaneko et al. (2007) suggest that anomalous pancreaticobiliary duct 
maljunction allows pancreatic juices to regurgitate into the common bile duct, which, by 
an unknown mechanism, causes the cleavage of trypsinogen into trypsin.  Consequently, 
trypsin cleaves the soluble form of lithostathine into the insoluble form, which flows 
down the common bile duct and aggregates to form an obstructive protein plug (see 




Figure 4. Hypothesized mechanism of protein plug formation in 
choledochal cysts. Image from Kaneko, K., et al., "Proteomic Analysis of 
Protein Plugs: Causative Agent of Symptoms in Patients with Choledochal 
Cyst." (Digestive Diseases and Sciences Vol. 52.8. 2007) 1979-86. Print. 
The description of protein plug formation by Kaneko et al. (2007) supports the 
findings of Turowski, Knisely, and Davenport (2011), who state that pressure and not 
pancreatic reflux causes the pathology found in choledochal cysts.  Turowski et al. (2011) 
hypothesize that there is an inverse correlation between amylase concentration in the bile 
and pressure in the choledochal cyst.  Turowski et al. (2011) also assert that epithelial and 
morphological pathology in choledochal cysts is positively correlated with choledochal 
cyst pressure and not with bile amylase concentration, which challenges the ideas of 
Babbitt et al. (1973). 
Mao, Tang, and Ruan (2008) offer a connection between the hypothesis 
formulated by Babbitt et al. (1973) that the pathology of choledochal cysts is caused by 
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regurgitated pancreatic juices and the findings of Turowski et al. (2011) that suggest that 
the pathology of choledochal cysts is predominately due to the increased intraductal 
pressure in patients with choledochal cysts. Mao et al. (2008) theorize that matrix 
metalloproteinase-1 and -2 are over expressed in the wall of the choledochal cyst 
compared to that of the gallbladder of a patient with a choledochal cyst and that of the 
common bile duct in a patient without a choledochal cyst.  Matrix metalloproteinases act 
to break down the extracellular matrix, which is important for the development and 
maintenance of the biliary tract (Mao, Tang and Ruan, 2008).  However, overexpression 
of matrix metalloproteinase-1 and -2 causes an increased break down of the extracellular 
matrix, which could lead to a weakening of the wall of the biliary tract (Mao, Tang and 
Ruan, 2008).  This weakening of the wall could lead to the formation of a cyst in the 
presence of high intraductal pressure (Mao, Tang and Ruan, 2008).  Mao et al. (2008) 
also assert that the regurgitation of the pancreatic juices into the common bile duct can 
stimulate the epithelial cells of the duct to increase expression of the matrix 











 The following is a case study about a 5-day-old, Japanese female who was 
brought to the doctor’s office because she developed jaundice and acholic stools.  The 
purpose of this case study is to bring to light the possible causes of these symptoms 




Jennifer Chang is a 5-day-old, Japanese female.  Jennifer is brought into the 
doctor’s office after she developed jaundice and acholic stools the previous evening.  
History of Present Illness 
Jennifer’s mother received no prenatal care, but insisted that she took good care of 
her baby while she was pregnant.  Jennifer’s mother denies drinking, smoking, or using 
drugs during pregnancy. Jennifer’s mother spontaneously went into labor, and Jennifer 
was delivered vaginally after 5 hours of labor at a gestational age of 39 weeks.  There 
were no complications during delivery. Jennifer’s mother was given an epidural before 
giving birth. Jennifer’s 1-minute APGAR score was a 9, with one point being lost due to 
acrocyanosis. After treating her with oxygen, Jennifer’s 5-minute APGAR score was a 
10.  Jennifer and her mother were released from the hospital the next day.  Jennifer’s 
mother states that Jennifer is nursing around 9 times a day and has regular bowel 
movements, which were brown until they started becoming pale in color last night.  
Jennifer’s mother said that Jennifer started becoming jaundiced last night.  However, 
Jennifer’s grandmother told Jennifer’s mother that jaundice in newborns is normal, so 
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Jennifer’s mother took Jennifer in to see the doctor this morning instead of taking her to 
the E.R. last night.  Jennifer’s mother says that Jennifer was fussy last night and that 
Jennifer still seems fussy this morning. 
Social and Family History 
Jennifer’s mother states that she and her boyfriend, Jennifer’s father, are in 
between jobs, but just got health insurance for Jennifer. Jennifer is living with her parents 
in her maternal grandparents’ house.  This is Jennifer’s mother’s first pregnancy and 
delivery, and this pregnancy was unintended but welcomed. Jennifer’s mother was 
healthy during her pregnancy.  Jennifer’s mother states that the only family history of 
illness is heart disease on the maternal side of the family and skin cancer and diabetes on 
the paternal side.  Jennifer’s mother states that there is no history of liver disease in the 
family.  
Physical Exam 
Jennifer’s vital signs, as recorded by the nurse, are as follows: 
Length: 19.5”    Weight: 7 lbs. 8 oz.    Head Circumference: 13.75”    BP: 76/46  
Temp: 99.1°F    RR: 45     HR: 143 
Physical exam findings for Jennifer Chang: 
General: Appears ill, but attentive. Appears irritable. 
Skin: Skin is soft and smooth, but jaundiced.  Skin is well perfused.  Mongolian 
spot present in the lower lumbar region. 
Head: Anterior fontanelle is soft and flat.  Skull is symmetrical.  Head 
circumference is within normal range. 
Face: Face is symmetrical.  No abnormal facies.  Negative Chvostek’s sign. 
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Eyes: Pupils are round and reactive to light.  Scleras are jaundiced.  Red reflex 
present.  Corneal reflex present. Cornea and lens are clear. 
Ears: Ears are normal in size, shape, and position.  Tympanic membrane visible 
with diffuse light reflex.  Acoustic blink reflex present. 
Nose: Both nostrils patent.  Nasal septum is midline. 
Mouth: Alveolar ridges normal.  Upper hard palate is intact with no cleft present.  
Tongue is pink and normal in size.  Tonsils could not be visualized. 
Neck: Neck is supple.  No lymphadenopathy.  Trachea midline. Clavicles contain 
no fractures. 
Chest/Lungs: No nasal flaring. No grunting, wheezing, stridor, or obstruction. Chest 
movement is symmetrical. No retractions present.  No tactile fremitus 
noted. No crackles, wheezes, or rhonchi upon auscultation. 
Heart: No cyanosis.  Regular rate and rhythm. Radial, carotid, femoral, Dorsalis 
pedis easily palpable bilaterally. Normal S1, S2. No murmurs, rubs, or 
gallops. 
Abdomen: No swelling or redness of umbilicus or area surrounding umbilicus. No 
distension. No hepatosplenomegaly. Bowel sounds present in all 4 
quadrants.  No masses noted upon palpation. 
Genitals: Labia and clitoris normal in size. Hymen and vaginal opening present. 
Musculoskeletal: Fingers and hands appear normal.  Spine normal. Hips symmetrical 
with full range of movement.  Legs symmetrical with slight bowing.  No 
torsion of the legs present. Feet appear normal. 
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Neurological: Cranial nerves 2-12 grossly intact.  Tone is normal.  Knee, ankle, biceps, 
Moro, stepping, rooting, suck, palmar, and plantar reflexes are present and 
symmetrical. 
Laboratory and Imaging Findings 
Jennifer’s laboratory results: 
Complete Blood Count 
RBC Count      4.1 x10
12
/L 
Hemoglobin      13.5g/dL 
Hematocrit      44.4% 
MCV       108.3fL 
MCH       32.9pg 
MCHC      30.4% 
RDW       17.0% 
White Cell Count     9.62 x10
9
/L 
Neutrophil Count (Absolute)    5.0 x10
9
/L 
Neutrophil Count (Relative)    52.0% 
Lymphocyte (Absolute)    4.0x10
9
/L 
Lymphocyte (Relative)    41.6% 
Monocyte Count (Absolute)    0.5 x10
9
/L 
Monocyte Count (Relative)    5.2% 
Eosinophil Count (Absolute)    0.1 x10
9
/L 
Eosinophil Count (Relative)    1.0% 





Basophil Count (Relative)    0.2% 
Platelet Count      244 x10
9
/L 
MPV       8.3fL 
Liver Function Tests 
ALT       60U/L 
ALP       450U/L 
AST       95U/L 
γGT       290U/L 
Total Bilirubin     15.3mg/dL 
Conjugated Bilirubin     10.1mg/dL 
Albumin      22g/L 
Glucose      89mg/dL 
Prothrombin Time     10.9s 
α-1 Antitrypsin     180mg/dL 
Cholesterol      163mg/dL 










Jennifer’s abdominal ultrasound results: 
There is a dilation of the common bile duct.  The gall bladder appears contracted. 






Jennifer’s HIDA scan results: 
Hepatic uptake at 5 minutes. Filling of gall bladder and choledochal cyst after 1 
hour. No intestinal activity after 5 hours. 
 
Diagnosis and Treatment 
Jennifer Chang is diagnosed with a type I choledochal cyst with complete 
obstruction of bile flow based on the lab results, abdominal ultrasound, and HIDA scan.  
Jennifer’s mother is informed of the diagnosis, and Jennifer’s doctor proceeds with the 
immediate excision of the choledochal cyst with a Roux-en-Y hepaticojujenostomy.  
After Jennifer’s discharge, her mother is told to bring Jennifer in for a follow-up 






Four days after Jennifer’s discharge from the hospital, Jennifer comes in for blood 
work and follow-up.  She shows no signs of cholestasis.  She appears less irritable than 
before surgery, and her mother says that she has not been fussy.  The incision site is 
healing well and shows no signs of infection or tenderness.  Jennifer’s mother is 
instructed to bring Jennifer in if Jennifer’s symptoms recur and every year for blood work 
to ensure that there is no recurrence of symptoms due to recurrence of the cyst, stricture 














Case Study Description 
Presentation 
Choledochal cysts may present in many forms primarily depending on age 
(Singham, Yoshida and Scudamore, 2009; Vijayaraghavan et al., 2006; Wiseman et al., 
2005).  This case study refers to a 5 day old female with a type I choledochal cyst.  The 
patient is Japanese, which correlates with the increased incidence of choledochal cysts 
among patients of Asian descent (Lipsett and Pitt, 2003). Because of the patient’s age, the 
patient’s underlying symptoms were jaundice and acholic stools (Vijayaraghavan et al., 
2006).  Jaundice occurs in patients with choledochal cysts because choledochal cysts 
cause an obstruction of the common bile duct, which mechanically inhibits the excretion 
of bilirubin (Iyanagi, Emi and Ikushiro, 1998). Jaundice created by obstruction of the 
biliary tract is a form of cholestatic jaundice due to the lack of clearance of bile from the 
biliary tract (Iyanagi, Emi and Ikushiro, 1998). Cholestatic jaundice creates a state of 
conjugated hyperbilirubinemia (Iyanagi, Emi and Ikushiro, 1998). Bilirubin must be 
conjugated to a molecule of glucuronic acid in order for it to be soluble in the bile; 
despite the prevention of excretion of bile by the obstruction of the biliary tract, the 
bilirubin continues to become conjugated (Iyanagi, Emi and Ikushiro, 1998).  This 
increase in concentration of conjugated bilirubin in the bile causes conjugated bilirubin to 
enter the blood plasma by an unknown mechanism, which directly causes conjugated 
hyperbilirubinemia (Iyanagi, Emi and Ikushiro, 1998). 
 Acholic stools are a result of cholestatic jaundice (Iyanagi, Emi and Ikushiro, 
1998). The normal brown color of stool is caused by the presence of bile salts in the stool 
26 
 
(Iyanagi, Emi and Ikushiro, 1998).  Due to the lack of clearance of bile from the biliary 
tract, these bile salts are not deposited in the stool, which causes the stool to be pale in 
color (Iyanagi, Emi and Ikushiro, 1998). 
Differential Diagnosis 
There are many possible causes of jaundice in infants (Blackburn, 1995).  Many 
infants develop physiological jaundice during the first few weeks of life because of the 
combination of the breakdown of fetal blood cells and the immaturity of the newborn 
liver (Blackburn, 1995).  However, physiological jaundice causes unconjugated 
hyperbilirubinemia because unconjugated bilirubin builds up in the blood plasma due to 
the fact that newborns cannot conjugate bilirubin (Blackburn, 1995). 
Cholestatic jaundice should always be thought of as a possibility in infants with 
jaundice because early recognition of cholestatic diseases is often essential in obtaining a 
good outcome (Moyer et al., 2004).  There are many causes of cholestatic jaundice in 
infants; most of these causes should be considered in the differential diagnosis of 
jaundiced infants (Moyer et al., 2004). These causes include the following diseases: 
biliary atresia, choledochal cyst, Alagille syndrome, inspissated bile, gall stones, neonatal 
hepatitis, progressive familial intrahepatic cholestasis, and α-1 antitrypsin deficiency 
(Moyer et al., 2004). 
Biliary atresia is a destruction or discontinuity of the extrahepatic biliary tract (de 
Carvalho, Ivantes and Bezerra, 2007). Biliary atresia has a high preponderance in people 
of Asian descent and in females, so biliary atresia is a likely diagnosis for the patient in 
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this case study (de Carvalho, Ivantes and Bezerra, 2007). Biliary atresia causes a 
complete obstruction to the flow of bile out of the liver, which results in jaundice, acholic 
stools, choluria, and hepatomegaly in most patients (de Carvalho, Ivantes and Bezerra, 
2007).  This disease presents the same way as choledochal cysts and has the same 
laboratory findings as choledochal cysts, but the treatment of biliary atresia is immediate 
surgery to restore bile flow, which makes it important to rule this disease out as soon as 
possible (de Carvalho, Ivantes and Bezerra, 2007).  An ultrasound should easily 
distinguish a choledochal cyst from biliary atresia (de Carvalho, Ivantes and Bezerra, 
2007).   
Alagille syndrome is a genetic disorder that presents as abnormalities in the liver, 
heart, eye, skeleton, facial structure, and kidneys (Turnpenny and Ellard, 2012).  The 
liver has a paucity of intrahepatic bile ducts, which causes cholestasis and jaundice 
(Turnpenny and Ellard, 2012).  The heart is marked by congenital heart disease in 
patients with Alagille syndrome (Turnpenny and Ellard, 2012). The eyes show posterior 
embryotoxon among other abnormalities (Turnpenny and Ellard, 2012).  Patients with 
Alagille syndrome have butterfly vertebrae along with other skeletal abnormalities 
(Turnpenny and Ellard, 2012). The faces of patients with Alagille syndrome are marked 
by prominent forehead, deep-set eyes, depressed nasal bridge, large ears, and a prominent 
mandible (Turnpenny and Ellard, 2012).  Many structural and functional abnormalities of 
the kidneys also present in patients with Alagille syndrome (Turnpenny and Ellard, 
2012).  However, during infancy, Alagille syndrome can present mainly as cholestatic 
jaundice (Turnpenny and Ellard, 2012).  Alagille syndrome is diagnosed using genetic 
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testing to test for the presence of Jag-1 and Notch-2 mutations, which are present in 
patients with Alagille syndrome (Turnpenny and Ellard, 2012). 
Inspissated bile is a thickening of bile, which can lead to an obstruction of the 
biliary tract and, thus, cholestatic jaundice (Bernstein, Braylan and Brough, 1969). This 
disease can produce similar laboratory results as a choledochal cyst, so ultrasound is used 
to distinguish the two (Bernstein, Braylan and Brough, 1969). 
Gall stones are caused by a precipitation of some component of the bile (Holcomb 
and Holcomb, 1990). Gall stones can lead to a blockage of the biliary tract and 
cholestatic jaundice (Holcomb and Holcomb, 1990).  Gall stones can cause similar 
laboratory test results as choledochal cysts, so an abdominal ultrasound is used to 
distinguish the two (Holcomb and Holcomb, 1990). 
Idiopathic neonatal hepatitis is an infection of the liver with an unknown etiology, 
which causes hepatic dysfunction and, possibly, cholestatic jaundice (Lough and 
Metrakos, 1967). Neonatal hepatitis may cause similar laboratory findings to patients 
with choledochal cysts, but an abdominal ultrasound easily distinguishes the two 
(Gubernick et al., 2000).   
Progressive familial intrahepatic cholestasis is an autosomal recessive genetic 
disorder in which the patient has a defect in bile formation (Hori, Nguyen and Uemoto, 
2010). This defect is due to a mutation in one of three genes: familial intrahepatic 
cholestasis 1, bile salt export pump, or multidrug resistant 3 (Hori, Nguyen and Uemoto, 
2010). Progressive familial intrahepatic cholestasis can produce similar laboratory 
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findings to choledochal cysts, but can be differentiated from choledochal cysts via 
ultrasound (Hori, Nguyen and Uemoto, 2010).   
α-1 antitrypsin deficiency is a genetic disorder characterized by a defect in α-1 
antitrypsin, which prevents the release of α-1 antitrypsin from liver cells and causes the 
death of these liver cells (Topic, Prokic and Stankovic, 2011).  α-1 antitrypsin deficiency 
presents in infants as cholestatic jaundice (Topic, Prokic and Stankovic, 2011). α-1 
antitrypsin deficiency is caused by an allele of the protease inhibitor locus on 
chromosome 14q32.1 that causes low serum levels of α-1 antitrypsin (Topic, Prokic and 
Stankovic, 2011).  α-1 antitrypsin deficiency is diagnosed by a deficiency in serum α-1 
antitrypsin (Topic, Prokic and Stankovic, 2011). Lab values for aspartate 
aminotransferase and alanine aminotransferase can also be used to differentiate between 
choledochal cysts and α-1 antitrypsin deficiency because aspartate aminotransferase and 
alanine aminotransferase are more increased in patients with α-1 antitrypsin deficiency 
than in patients with a choledochal cyst because α-1 antitrypsin deficiency directly causes 
hepatocellular damage, whereas choledochal cysts cause hepatocellular damage indirectly 
and to a lesser extent (Topic, Prokic and Stankovic, 2011). 
History of Present Illness 
Many choledochal cysts are diagnosed via a prenatal ultrasound (Wong et al. 
2005).  To avoid this immediate diagnosis, this patient’s mother did not have prenatal 
care for financial reasons.  Newborns with choledochal cysts can be born without any 
problems and develop jaundice when complete obstruction occurs, which explains why 
this patient had an uncomplicated birth.  The patient became jaundiced and had acholic 
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stools the night before she was brought to the pediatrician’s office.  Also, because 
choledochal cysts may cause pain, the patient was acting fussy from the time that she 
developed her symptoms. 
Family History 
The patient had no family history of liver disease, which correlates with the fact 
that familial cases of choledochal cysts are very rare (Clifton et al., 2006). 
Physical Examination 
Other than jaundice and fussiness, the patient’s physical examination showed no 
abnormal findings. 
Laboratory Work-up 
In order to distinguish between physiological and cholestatic jaundice, the 
patient’s serum direct bilirubin and serum total bilirubin were tested (Moyer et al., 2004).  
Serum total bilirubin tests the concentration of bilirubin in the patient’s blood and serum 
(Moyer et al., 2004). Direct bilirubin tests the concentration of conjugated bilirubin in the 
patient’s blood (Moyer et al., 2004).  In a patient with cholestatic jaundice, the 
conjugated bilirubin is elevated if it is greater than 1.0 mg/dL or more than 20% of the 
total bilirubin if the total bilirubin is greater than 5 mg/dL (Moyer et al., 2004).  An 
abnormality in these tests indicates a blockage in bile flow (Moyer et al., 2004). 
To attempt to elucidate the cause of the cholestatic jaundice, the following tests 
were ordered: complete blood count with differential, liver function tests, blood glucose, 
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prothrombin time, α-1 antitrypsin, urine reducing substances, and an abdominal 
ultrasound (Moyer et al., 2004). In children with choledochal cysts, the pertinent lab 
results are as follows: elevated alkaline phosphatase, elevated serum aspartate 
aminotransferase, elevated serum alanine aminotransferase, and elevated gamma 
glutamyl transferase (see table 1) (Singhavejsakul and Ukarapol, 2008).   
Among other places, alkaline phosphatase is located in the bile ducts (Toda et al., 
1980).  In the presence of cholestasis, the biliary alkaline phosphatase is regurgitated into 
the blood stream (Toda et al., 1980).  This regurgitation causes the increase in serum 
alkaline phosphatase that is seen in patients with choledochal cysts (Toda et al., 1980). 
Gamma glutamyl transferase is located, among other places, in the small bile 
ductule epithelium (D'Agata and Balistreri, 1999).  Cholestasis causes the increase of 
gamma glutamyl transferase, the solubilization of gamma glutamyl transferase, and, 
therefore, the increase in the serum gamma glutamyl transferase level (D'Agata and 
Balistreri, 1999).  Despite its ubiquity throughout the body, gamma glutamyl transferase 
elevation is limited to disease of the liver (D'Agata and Balistreri, 1999). Therefore, a rise 
in both alkaline phosphatase and gamma glutamyl transferase indicates cholestasis 
(D'Agata and Balistreri, 1999). 
Aspartate aminotransferase and alanine aminotransferase are located in 
hepatocytes (D'Agata and Balistreri, 1999).  Serum values of these enzymes increase 
when they are released from hepatocytes due to hepatocyte death (D'Agata and Balistreri, 
1999). A choledochal cyst is not a hepatocellular disease, but the bile stasis caused by a 
choledochal cyst is toxic to hepatocytes, and this toxicity kills hepatocytes and leads to a 
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slight increase in the serum values of these enzymes in patients with choledochal cysts 


























Table 1. Example laboratory report for a 5 year old female patient with a choledochal 
cyst.  All reference values come from Soldin et al. (Soldin et al., 2007). Prothrombin 
Time reference range comes from Rosenthal (Rosenthal, 1997). 
Test  5 Day Old 
Reference Values 
Change in Patient with 
Choledochal Cyst 
Example Value in 
Patient with 
Choledochal Cyst 
CBC     
 RBC Count 3.1-5.2 x10
12
/L  4.1 x10
12
/L 
 Hemoglobin 11.8-17.7g/dL  13.5 g/dL 
 Hematocrit 34.4-50.8%  44.4% 
 MCV 86.5-108.3fL  108.3fL 
 MCH 30.6-36.8pg  32.9pg 
 MCHC 33.6-35.7%  30.4% 
 RDW 14.4-19.4%  17.0% 
 White Cell Count 5.86-16.0 x10
9
/L  9.62 x10
9
/L 




/L  5.0 x10
9
/L 
 Neutrophil Count 
(Relative) 
21.6-59.0%  52.0% 
 Lymphocyte (Absolute) 1.17-5.4 x10
9
/L  4.0 x10
9
/L 
 Lymphocyte (Relative) 10-52.9%  41.6% 




/L  0.5 x10
9
/L 
 Monocyte Count 
(Relative) 
1.3-18.7%  5.2% 




/L  0.1 x10
9
/L 
 Eosinophil Count 
(Relative) 
0-7.5%  1.0% 




/L  0.02 x10
9
/L 
 Basophil Count (Relative) 0-1%  0.2% 
 Platelet Count 95-354x10
9
/L  244 x10
9
/L 
 MPV 7.8-9.3fL  8.3fL 
LFTs     
 ALT 7-54U/L Mildly Elevated 60U/L 
 ALP 65-357U/L Elevated 450U/L 
 AST 20-95U/L Mildly Elevated 95U/L 
 γGT 18-148U/L Elevated 290U/L 
 Total Bilirubin <11.7mg/dL Elevated 15.3mg/dL 
 Conjugated Bilirubin <0.6mg/dL Elevated 10.1mg/dL 
 Albumin 18-40g/L  22g/L 
Glucose  47-110mg/dL  89mg/dL 
Prothrombin 
Time 
 10-15.3 s  10.9s 
α-1 
Antitrypsin 
 92-282mg/dL  180mg/dL 
Cholesterol  56-198mg/dL  163mg/dL 
Urine reducing 
substances 





Choledochal cysts are confirmed with an abdominal ultrasound (Moyer et al., 
2004). This patient showed a choledochal cyst on the ultrasound.  There was 
communication with the gall bladder, and the gall bladder was contracted (see figure 5). 
 
Figure 5. Ultrasound of neonate with a choledochal cyst. A. Transverse cross-sectional 
view B. Transverse cross-sectional view inferior to A C. Transverse cross-sectional view 
of the junction of the cystic duct and the choledochal cyst. Image from Clifton, M.S., et 




After confirming a diagnosis of a choledochal cyst, a Hepatobiliary Iminodiacetic 
Acid (HIDA) scan was performed to measure the degree of obstruction to biliary flow 
(Lugo-Vicente, 1995).  The HIDA scan showed complete obstruction of bile flow (see 
figure 6). 
 
Figure 6. HIDA scan of a neonate with a choledochal cyst. Hepatic uptake at 5 minutes. 
Filling of gall bladder and choledochal cyst after 1 hour. No intestinal activity after 5 
hours. Image from Al-Salem, A.H., “Choledochal cyst.” (Saudi Medical Journal Vol. 
25.1. 2004) 99-102. Print. 
Treatment 
Due to the complete obstruction to bile flow, the cyst was surgically excised 
immediately, and a Roux-en-Y reconstruction of the biliary tract was performed 
(Shimotakahara et al., 2005).  The patient is being followed long term using laboratory 
tests every year in order to detect any potential complications, including recurrence of the 
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cyst, stricture of the anastomosis, and cholangiocarcinoma (Shimotakahara et al., 2005; 
























The pathogenesis of choledochal cysts is very controversial. The current research 
seems to signify that the presence of anomalous pancreaticobiliary duct maljunction 
causes the reflux of pancreatic juices into the common bile duct, which causes multiple 
things to happen (Babbitt, Starshak and Clemett, 1973).  First, reflux of pancreatic juice 
causes epithelial cells to over express matrix metalloproteinase-1 and -2, which work to 
break down the extracellular matrix more than in a patient without a choledochal cyst 
(Mao, Tang and Ruan, 2008).  Second, the trypsinogen in the pancreatic juices gets 
activated allowing activated trypsin to cleave lithostathine, which is also present in the 
pancreatic juices, into its insoluble form, lithostathine S1, which allows lithostathine S1 
to aggregate in the common bile duct and form a protein plug that obstructs the common 
bile duct (Kaneko et al., 2007).  This protein plug increases the pressure in the biliary tree 
(Kaneko et al., 2007).  This increased pressure, along with a weakened duct wall caused 
by the matrix metalloproteinase over activity, causes the formation of a cyst in the biliary 
tree (Mao, Tang and Ruan, 2008). 
This theory about the etiology of the disease does not take into account those 
cases of choledochal cysts that form in the absence of anomalous pancreaticobiliary duct 
maljunction.  However, the definition of anomalous pancreaticobiliary duct maljunction 
is not agreed upon by physicians (Okada et al., 2002). For this reason, a clear definition 
of anomalous pancreaticobiliary duct maljunction needs to be produced because this 
anomaly might be present in more or less cases of choledochal cysts than is reported in 
the literature due to different definitions of the anomaly (Okada et al., 2002). 
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The current treatment of choledochal cysts is evolving from open abdomen Roux-
en-Y hepaticojejunostomy to laparoscopic Roux-en-Y hepaticojejunostomy (Santore et 
al., 2001). Laparoscopic Roux-en-Y hepaticojejunostomy is very prevalent in Asian 
countries and is becoming more prevalent in the United States (Santore et al., 2001). The 
laparoscopic approach is generally preferred when possible because it decreases the 
chance for infection, decreases blood loss, and decreases the cosmetic consequences 
(Santore et al., 2001). Despite this, both approaches are equally successful (Santore et al., 
2011). 
Upon elucidation of the etiology of the disease, the treatment of choledochal cysts 
could become much more directed at the cause of the disease as opposed to the 
symptoms.  Discovery of the etiology could also lead to a better understanding of the 
difference in presentation of choledochal cysts between age groups, and it could 
ultimately lead to an understanding of the curious epidemiology of the disease. 
Many pediatric clinicians do not encounter patients that present with cholestatic 
jaundice during their time practicing because it affects approximately 0.04% of infants 
(Moyer et al., 2004).  Because of this, cholestatic jaundice is occasionally initially 
diagnosed as neonatal jaundice (Moyer et al., 2004).  This case study aims to elucidate 
the possible causes of cholestatic jaundice in infants and to bring a greater appreciation to 
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